Abbott Can't Shake Roxane's Suit Over Generic Norvir

Law360, New York (June 21, 2012, 10:21 PM EDT) -- An Ohio federal judge on Thursday blocked Abbott Laboratories' bid to toss a suit by generic-drug maker Roxane Laboratories Inc. challenging two of Abbott's patents for its HIV drug Norvir in Roxane's effort to market generic versions of the drug.

U.S. District Judge Michael H. Watson rejected Abbott's bid to toss the suit or have it transferred to Delaware, finding Roxane had remained uncertain about the state of the two of patents covering Norvir ever since it filed an abbreviated new drug application with the U.S....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.